Our new
strategy

This year, we embarked on a bold new strategy that will see us push the boundaries of clinical innovation over the next three years. It outlines how we will work with our partners to bring about transformational change that will improve patient experiences and outcomes.

“Our mission remains centred on helping clinicians and healthcare leaders to embrace innovation – supporting them to know, act, connect, and work towards better, fairer, sustainable healthcare.”

Dr Jean-Frédéric Levesque, Chief Executive, ACI and Deputy Secretary, Clinical Innovation and Research

Our strategic areas to push the boundaries of clinical innovation

1. Taking a portfolio approach to clinical innovation

2. Engaging

partnering with agility

3. Informing

triangulating sources of evidence

4. Enabling

a toolbox of transformation methods

Discover more about our Strategy 2023–2026

Listening to our stakeholders

We heard from hundreds of stakeholders to create our strategy, including staff, consumers, clinicians and health system leaders, locally and internationally.

We gathered insights through:

  • staff surveys and workshops
  • environmental scanning
  • SWOT analysis (strengths, weaknesses, opportunities and threats)
  • interviews
  • consensus-building workshops.

We acknowledge and thank all individuals who participated in the Strategic Planning Advisory Committee and working groups who continue to drive our strategy forward.

Bringing the strategy to life

Enacting our new strategy involves re-balancing our work to direct the resources necessary towards projects that drive transformational change.

We are addressing priority challenges that align to the NSW Future Health Strategy.

We developed an implementation blueprint for the next three years, including strategic initiatives that involve:

  • adopting agile methods to support the development of clinical guidance
  • taking a purposeful approach to prioritisation
  • taking a balanced approach to refine, evolve and transform healthcare innovations
  • progressing high potential projects from pilots to scaled programs using a pipeline approach to innovation
  • ensuring there is system-wide engagement with clinicians, consumers and health leaders.
Back to top